We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$468M
AUM Growth
+$160M
Cap. Flow
+$174M
Cap. Flow %
37.12%
Top 10 Hldgs %
25.86%
Holding
170
New
51
Increased
61
Reduced
22
Closed
28

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$11.7M
2
JACK icon
Jack in the Box
JACK
+$10M
3
CVSA
Covista Inc
CVSA
+$9.81M
4
POSH
Poshmark, Inc. Class A Common Stock
POSH
+$6.39M
5
VMW
VMware, Inc
VMW
+$6.22M

Top Sells

Rank Stock Value
1
DLTR icon
Dollar Tree
DLTR
+$5M
2
CIVI
Civitas Resources
CIVI
+$4.58M
3
BABA icon
Alibaba
BABA
+$4.31M
4
CNC icon
Centene
CNC
+$4.16M
5
PRU icon
Prudential Financial
PRU
+$3.94M

Sector Composition

Rank Sector Weight
1 Technology 14.78%
2 Consumer Discretionary 12.04%
3 Healthcare 11.59%
4 Financials 10.04%
5 Materials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAL icon
101
Caleres
CAL
$486M
$1.21M 0.26%
+53,384
New +$1.27M
STRT icon
102
STRATTEC Security
STRT
$349M
$1.19M 0.25%
+32,012
New +$1.24M
OXY.WS icon
103
Occidental Petroleum Corp Warrants
OXY.WS
$34.5B
$1.18M 0.25%
+93,922
New +$1.29M
BWA icon
104
BorgWarner
BWA
$14.1B
$1.17M 0.25%
29,358
+9,027
+44% +$363K
FONR
105
DELISTED
Fonar
FONR
$1.15M 0.25%
76,883
+22,344
+41% +$359K
HBI
106
DELISTED
Hanesbrands
HBI
$1.15M 0.25%
+68,804
New +$1.17M
ECHO
107
EchoStar
ECHO
$25.9B
$1.01M 0.22%
38,173
-32,418
-46% -$856K
HYRE
108
DELISTED
HyreCar Inc. Common Stock
HYRE
$979K 0.21%
207,745
+131,881
+174% +$824K
ORN icon
109
Orion Group Holdings
ORN
$396M
$975K 0.21%
258,517
+153,319
+146% +$682K
SNAX
110
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$953K 0.2%
+16,069
New +$1.15M
WEYS icon
111
Weyco Group
WEYS
$441M
$942K 0.2%
39,307
+771
+2% +$18K
GSV
112
DELISTED
Gold Standard Ventures Corp.
GSV
$921K 0.2%
2,077,445
+1,826,770
+729% +$843K
FL
113
DELISTED
Foot Locker
FL
$913K 0.2%
20,926
+402
+2% +$19.1K
PMD
114
DELISTED
Psychemedics Corporation
PMD
$878K 0.19%
126,477
+1,162
+0.9% +$9.29K
AGS
115
DELISTED
PlayAGS
AGS
$874K 0.19%
128,647
+2,402
+2% +$18.4K
VEON icon
116
VEON
VEON
$3.87B
$819K 0.18%
19,171
+14,477
+308% +$706K
MLR icon
117
Miller Industries
MLR
$606M
$815K 0.17%
+24,389
New +$842K
HLLY icon
118
Holley
HLLY
$382M
$782K 0.17%
+60,243
New +$729K
ZNGA
119
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$778K 0.17%
+121,474
New +$838K
HHH icon
120
Howard Hughes
HHH
$3.91B
$772K 0.17%
7,958
-11,687
-59% -$1.02M
VTOL icon
121
Bristow Group
VTOL
$1.38B
$739K 0.16%
23,323
-8,776
-27% -$296K
IBEX icon
122
IBEX
IBEX
$496M
$705K 0.15%
+54,634
New +$867K
PARA
123
DELISTED
Paramount Global Class B
PARA
$578K 0.12%
19,162
+390
+2% +$13.4K
GRPN icon
124
Groupon
GRPN
$933M
$541K 0.12%
23,335
+464
+2% +$10.8K
GAIA icon
125
Gaia
GAIA
$48.1M
$480K 0.1%
56,037
+1,159
+2% +$10.8K
3 4
5
6 7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Invenomic Capital Management held 170 positions worth $468M, up 52% from $308M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $174M of net new capital in Q4 2021, opening 51 new positions and adding to 61 existing holdings. Its largest new stake was AT&T: 626,014 shares worth $11.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 7.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Civitas Resources, an estimated $4.58M trimmed.

  • Invenomic Capital Management's largest Q4 2021 buy was AT&T: 626,014 shares worth $11.6M.
  • Invenomic Capital Management added most to Cigna in Q4 2021, an estimated $5.95M increase.
  • Invenomic Capital Management's biggest Q4 2021 reduction was Civitas Resources, cutting an estimated $4.58M.
  • Invenomic Capital Management fully exited Dollar Tree in Q4 2021, selling an estimated $5M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $468M portfolio in Q4 2021.
  • Invenomic Capital Management opened 51 new positions and closed 28 in Q4 2021.
  • Invenomic Capital Management's portfolio value rose 52% quarter-over-quarter to $468M.

Based on Invenomic Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.